Posted: 03/31/09 at 01:41 pm
--------------------------------------------------------------------------------
A friend of mine forwarded me this info
http://www.intelliject.com/epicard.php
Posted: 01/04/10 at 07:37 am
--------------------------------------------------------------------------------
Here's another article:
http://www2.timesdispatch.com/rtd/business/health_med_fit/article/COVR04_20100103-172003/315120/ I really wish they could give specifics at how long to expect to see these available.
Posted: 01/04/10 at 01:17 pm
--------------------------------------------------------------------------------
01/04/10 at 07:37 am, JR wrote:
Here's another article:
http://www2.timesdispatch.com/rtd/business/health_med_fit/article/COVR04_20100103-172003/315120/ I really wish they could give specifics at how long to expect to see these available.
The last two paragraphs of that article:
Success, for them, will be when their auto-injector is in the hands of people, like themselves, at risk of severe allergic reactions, Eric Edwards said. That is at least a year or more down the road.
"With this partnership, Intelliject is responsible for finishing the development of the product through [Food. and Drug Administration] approval," Eric Edwards explained. "It's a late-stage product. We will be filing our new drug application with the FDA [in. 2010]. . . . Within the next couple of years this product should be on the market."
Posted: 08/12/11 at 10:24 pm
--------------------------------------------------------------------------------
An Interview with Intelliject’s CEO Spencer Williamson
http://medgadget.com/2011/08/an-interview-with-intellijects-ceo-spencer-williamson.html Some Q & A
Posted: 08/13/11 at 01:04 pm
--------------------------------------------------------------------------------
Quote:
The FDA has tentatively approved the e-cue™ for emergency treatment of allergic reactions including anaphylaxis. Tentative approval means that the product review is complete and the submission met the FDA’s requirements to be approved. The FDA reserves final approval of the product, however, until all exclusivity or patent challenges have been resolved, specifically the current patent litigation brought against Intelliject by King Pharmaceuticals, Inc. (King) and Meridian Medical Technologies, Inc. (Meridian). Pfizer Inc., the world’s largest pharmaceutical company, according to published data, owns King and Meridian. Final FDA approval is required before a product can be marketed in the United States.
did they fight against twinject? Seems to me, the twin is closer then the ecue.